Domantis Ltd.

The ability of web-based "crowdfunding" platforms to more easily attract and aggregate investment funding for start-up companies in the UK biotech sector is to be put to the test with Capital Cell ,

Kymab Ltd. CEO Dr David Chiswell OBE has more than 30 years of experience in the biotechnology industry, having co-founded Cambridge Antibody Technology Group PLC in 1990, a company that origina

Touting the success of its efforts to overhaul R&D, as evidenced by the late-stage assets presented during GlaxoSmithKline PLC ’s Dec. 3 R&D day, the company noted the time has come to revamp manuf

After breaking down R&D into small biotech-like drug performance units, GSK is now using these as building blocks for larger, fully integrated business units spanning discovery to approval. Melanie Se